• About us
• Contact

Advertisement

Person › Details

Hervé Affagard (MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT))

Affagard, Hervé (MaaT Pharma 201507 CEO)

 

	Organisation	MaaT Pharma (Microbiota as a Therapy) (Euronext: MAAT)
	Product	microbial therapy

Record changed: 2023-06-22

Advertisement

More documents for Hervé Affagard

• [1] MaaT Pharma. (6/21/23). "Press Release: MaaT Pharma Announces New Appointments to the Board and Executive Team". Lyon....
• [2] MaaT Pharma. (10/15/21). "Press Release: MaaT Pharma Launches Its Initial Public Offering on the Regulated Market of Euronext in Paris [ Not for US, CA, AU, JP or RK ]". Lyon....
• [3] MaaT Pharma. (12/1/20). "Press Release: MaaT Pharma Announces Series B Extension and Final Closing with Total of €25 Million ($29.5 Million)". Lyon....
• [4] MaaT Pharma. (5/28/20). "Press Release: MaaT Pharma Appoints Savita Bernal as Chief Business Officer". Lyon....
• [5] MaaT Pharma. (2/5/20). "Press Release: MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics". Lyon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.